02 Oct Odylia CEO & CSO, Ashley Winslow, discusses the Nonprofit Biotech model with Talking Biotech host Kevin Folta
Posted at 12:03h
in Uncategorized
Atlanta, GA — September 9, 2023
This episode has two parts. The first part discusses how Odylia Therapeutics is addressing rare disease, using a novel non-profit model. The second half address two rare genetic eye diseases and the approaches being designed to address them. Dr. Ashley Winslow, CEO/CSO of Odylia, describes how a non-profit is well suited to address these rare diseases, using strategies that leverage capacities in rare disease patient communities coupled to their expertise in drug discovery.
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, professor of the horticultural sciences department at the University of Florida.